von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects with peripheral or coronary atherosclerosis

Blood Coagulation and Fibrinolysis

Volumn 10, Issue 6, 1999, Pages 375-380

  Blann, A D ^a   McCollum, C N ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Atherosclerosis; Soluble thrombomodulin; von Willebrand factor

Indexed keywords

BIOCHEMICAL MARKER; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTERY SURGERY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DISEASE MARKER; FEMALE; HEART INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; STROKE; VASCULAR ENDOTHELIUM;

EID: 0032851331     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199909000-00008     Document Type: Article

References (31)

1. 1. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.
2. 2. Blann AD, Lip GYH. The endothelium in cardiovascular disease: functions, assessment and implications. Blood Coag Fibrinol 1998; 9: 297-306.
3. 3. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90: 244-248.
4. 4. Boneu B, Abbal M, Plante J, Bierme R. Factor VIII complex and endothelial damage. Lancet 1975; i: 1430.
5. 5. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease, Br J Haematol 1994; 88: 601-607.
6. 6. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction. Br Heart J 1992; 66: 351-355.
7. 7. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. New Engl J Med 1995; 332: 635-641.
8. 8. Boffa MC. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker. Haemostasis 1996; 26 (suppl 4): 233-243.
9. 9. Seigneur M, Dufoureq P, Conri C, Constans J, Mercie P, Pruvost A, et al. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993; 71: 423-431.
10. 10. Blann AD, Amiral J, McCollum CN. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997; 59: 115-120.
11. 11. Jansson JH, Boman K, Brannstrom M, Nilsson TK. Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long term anticoagulant treatment. Eur Heart J 1996; 17: 1503-1505.
12. 12. Wada H, Mori Y, Shimura M, Hiyoyama K, Ioka M, Nakasaki T, et al. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenia purpura patients with severe vascular endothelial cell injuries. Am J Haematol 1998; 58: 189-194.
13. 13. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87 (suppl II): II-56-II-65.
14. 14. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. Arterioscler Thromb 1994; 14: 1885-1891.
15. 15. Kartchner MM, McRae LP, Morrison FD. Non-invasive detection and evaluation of carotid occlusive disease. Arch Surg 1973; 106: 528-535.
16. 16. Fowkes FGR, Housley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ. Edinburgh artery study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20: 384-392.
17. 17. Schroll M, Munck O. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population of 60 year old men and women. J Chron Dis 1981; 34: 261-269.
18. 18. Vogt MT, McKenna M, Wolfson SK, Kuller LH. The relationship between ankle brachial pressure index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis 1993; 101: 191-202.
19. 19. Palomaki P, Mietten H. Diagnosis of acute myocardial infarction by MONICA and FINMONICA. Diagnostic criteria in comparison with hospital discharge diagnosis. J Clin Epidemiol 1994; 47: 659-666.
20. 20. World Medical Association Declaration of Helsinki. Cardiovasc Res 1997; 35: 2-3.
21. 21. Hatano S. Experience from a multicentre stroke register. A preliminary report. Bull WHO 1976; 54: 541-545.
22. 22. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962; 27: 645-658.
23. 23. Buchwald H, Boen JR, William SE. POSCH: twenty years follow up [abstract]. Atherosclerosis 1997; 134: 1.
24. 24. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, et al., and the PLAT study group. The PLAT study: haemostatic function in relation to atherothrombotic ischaemic events in vascular disease patients. Arterioscler Thromb 1992; 12: 1063-1070.
25. 25. Violi F, Criqui M, Longoni A, Castiglioni C, on behalf of the ADEP Group. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the ADEP study. Atherosclerosis 1996; 120: 25-35.
26. 26. Marchmann P, Nawroth P, Wahl P, Jespersen J. Diet, gender and plasma thrombomodulin. Thromb Res 1996; 82: 439-443.
27. 27. Katz D, Baptista J, Azen SP, Pike MC. Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics 1987; 34: 469-474.
28. 28. Hertzer NR, Beven EG, Young JR, O'Hara PJ, Ruschhaupt WF, Graor RA, et al. Coronary artery disease in peripheral vascular patients. Ann Surg 1984; 199: 223-233.
29. 29. Alexandrova NA, Gibson WC, Norris JW, Maggisano R. Carotid artery stenosis in peripheral vascular disease. J Vase Surg 1996; 23: 645-649.
30. 30. Sanguigni V, Gallu M, Strano A. Incidence of carotid artery atherosclerosis in patients with coronary artery disease. Angiology 1993; 44: 34-38.
31. 31. Boneu B, Leger P, Arnaud C. Haemostatic system activation and prediction of vascular events in patients presenting with stable peripheral arterial disease of moderate severity. Blood Coag Fibrinol 1998; 9: 129-135.